Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TRIMEBUTINE AA PHARMA INC Actual shortage 100MG Updated Report 2023-02-04 183589
CEFAZOLIN FOR INJECTION STERIMAX INC Actual shortage 1G Updated Report 2023-02-04 183209
MOXIFLOXACIN PRO DOC LIMITEE Actual shortage 400MG Updated Report 2023-02-04 183506
BUTRANS 20 PURDUE PHARMA Actual shortage 20MCG Updated Report 2023-02-04 183519
DIPHENIST 50MG/ML OMEGA LABORATORIES LIMITED Actual shortage 50MG Updated Report 2023-02-04 183620
ATROPINE SULFATE INJECTION USP PFIZER CANADA ULC Resolved 1MG Updated Report 2023-02-04 173235
ACH-APIXABAN ACCORD HEALTHCARE INC Resolved 5MG Updated Report 2023-02-04 175838
ACETAZOLAMIDE AA PHARMA INC Actual shortage 250MG Updated Report 2023-02-04 183593
JAMP-AMITRIPTYLINE TABLETS JAMP PHARMA CORPORATION Actual shortage 25MG Updated Report 2023-02-03 154949
JAMP-AMITRIPTYLINE TABLETS JAMP PHARMA CORPORATION Actual shortage 50MG Updated Report 2023-02-03 154946

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
5% DEXTROSE AND 0.225% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 2.25MG 50MG Updated Report 2023-02-02 148686
LEVEMIR FLEXTOUCH NOVO NORDISK CANADA INC To be discontinued 100UNIT New Report 2023-02-01 182902
NOVORAPID NOVO NORDISK CANADA INC To be discontinued 100UNIT Updated Report 2023-02-01 182889
OMNIPAQUE 240 GE HEALTHCARE CANADA INC To be discontinued 518MG New Report 2023-01-31 182760
OMNIPAQUE 180 GE HEALTHCARE CANADA INC To be discontinued 388MG New Report 2023-01-31 182757